Quantum BioPharma's LUCID-MS program is built around the unmet need for MS therapies capable of directly protecting or ...

The FDA has placed a clinical hold on Quantum’s application seeking clearance to begin a Phase 2 trial testing Lucid-MS in ...

Taoiseach Micheál Martin has said he wants to see patients living with Friedreich's Ataxia in Ireland have access to the first treatment for the condition "as fast as we possibly can".

Our data suggest that MS 001 may help achieve several of the field’s objectives simultaneously: greater fat-selective ...

Ms. Rachel, a YouTube entertainer known for her vast children’s audience, visited on Monday the Delaney Hall immigration ...

Nurix (NRIX) stays a Strong Buy as bexobrutideg posts 83% ORR in r/r CLL and lands a $2.3B Roche deal—review the catalysts, ...

A lawyer for one of the Ulm5, a group of five activists accused of damaging the offices of a global defence company in the German city of Ulm last September, has said that the conditions under which ...

MCID in their MG-ADL with a mean >4 point improvement in MG-ADL observed in Phase 1 study of Subcutaneous BRIUMVI in patients with MG (n=11) ...

A conversation with Gina Kolata, who covers breakthroughs in medical science. By Terence McGinley Times Insider explains who ...

Knowable Magazine reports on a revolutionary CAR T-cell therapy, originally for cancer, now showing promise for autoimmune ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has ...

Adults with MS had lower annualized relapse rates with diroximel fumarate vs. dimethyl fumarate treatment at 1 and 2 years, ...